Literature DB >> 2174912

Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

H Schunkert1, V J Dzau, S S Tang, A T Hirsch, C S Apstein, B H Lorell.   

Abstract

We compared the activity and physiologic effects of cardiac angiotensin converting enzyme (ACE) using isovolumic hearts from male Wistar rats with left ventricular hypertrophy due to chronic experimental aortic stenosis and from control rats. In response to the infusion of 3.5 X 10(-8) M angiotensin I in the isolated buffer perfused beating hearts, the intracardiac fractional conversion to angiotensin II was higher in the hypertrophied hearts compared with the controls (17.3 +/- 4.1% vs 6.8 +/- 1.3%, P less than 0.01). ACE activity was also significantly increased in the free wall, septum, and apex of the hypertrophied left ventricle, whereas ACE activity from the nonhypertrophied right ventricle of the aortic stenosis rats was not different from that of the control rats. Northern blot analyses of poly(A)+ purified RNA demonstrated the expression of ACE mRNA, which was increased fourfold in left ventricular tissue obtained from the hearts with left ventricular hypertrophy compared with the controls. In both groups, the intracardiac conversion of angiotensin I to angiotensin II caused a comparable dose-dependent increase in coronary resistance. In the control hearts, angiotensin II activation had no significant effect on systolic or diastolic function; however, it was associated with a dose-dependent depression of left ventricular diastolic relaxation in the hypertrophied hearts. These novel observations suggest that cardiac ACE is induced in hearts with left ventricular hypertrophy, and that the resultant intracardiac activation of angiotensin II may have differential effects on myocardial relaxation in hypertrophied hearts relative to controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174912      PMCID: PMC329826          DOI: 10.1172/JCI114924

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle.

Authors:  R J Freer; A J Pappano; M J Peach; K T Bing; M J McLean; S Vogel; N Sperelakis
Journal:  Circ Res       Date:  1976-08       Impact factor: 17.367

2.  Concentrations of angiotensin-converting enzyme in tissues of the rat.

Authors:  D W Cushman; H S Cheung
Journal:  Biochim Biophys Acta       Date:  1971-10

3.  Direct myocardial effects of angiotensin II.

Authors:  P J Dempsey; Z T McCallum; K M Kent; T Cooper
Journal:  Am J Physiol       Date:  1971-02

4.  Improved automated lactate determination.

Authors:  C S Apstein; E Puchner; N Brachfeld
Journal:  Anal Biochem       Date:  1970-11       Impact factor: 3.365

5.  Analysis and correction of pressure wave distortion in fluid-filled catheter systems.

Authors:  H L Falsetti; R E Mates; R J Carroll; R L Gupta; A C Bell
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

6.  Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin.

Authors:  P Needleman; G R Marshall; B E Sobel
Journal:  Circ Res       Date:  1975-12       Impact factor: 17.367

7.  Angiotensin II-forming pathways in normal and failing human hearts.

Authors:  H Urata; B Healy; R W Stewart; F M Bumpus; A Husain
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Comparison of acute alterations in left ventricular relaxation and diastolic chamber stiffness induced by hypoxia and ischemia. Role of myocardial oxygen supply-demand imbalance.

Authors:  T Serizawa; W M Vogel; C S Apstein; W Grossman
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Positive chronotropic and inotropic effects of angiotensin II in the dog heart.

Authors:  M Kobayashi; Y Furukawa; S Chiba
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

View more
  92 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.

Authors:  M Hamon; C Amant; C Bauters; F Richard; N Helbecque; E McFadden; J M Lablanche; M Bertrand; P Amouyel
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 3.  Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.

Authors:  W Motz; B E Strauer
Journal:  Clin Investig       Date:  1992

Review 4.  So! What's aging? Is cardiovascular aging a disease?

Authors:  Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

5.  MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.

Authors:  Gaurav Mehta; Sivarajan Kumarasamy; Jian Wu; Aaron Walsh; Lijun Liu; Kandace Williams; Bina Joe; Ivana L de la Serna
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

Review 6.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 7.  Diastolic function in hypertension.

Authors:  R A Phillips; J A Diamond
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

8.  Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril.

Authors:  E M Mervaala; I Paakkari; J Laakso; R Nevala; T M Teräväinen; F Fyhrquist; H Vapaatalo; H Karppanen
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.

Authors:  B D Hoit; Y Shao; A Kinoshita; M Gabel; A Husain; R A Walsh
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 10.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.